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Résumé en
anglais
Familial isolated pituitary adenoma (FIPA) occurs in families and is unrelated to
multiple endocrine neoplasia type 1 and Carney complex. Mutations in AIP account
only for 15-25% of FIPA families. CDKN1B mutations cause MEN4 in which affected
patients can suffer from pituitary adenomas. With this study, we wanted to assess
whether mutations in CDKN1B occur among a large cohort of AIP mutation-negative
FIPA kindreds. Eighty-eight AIP mutation-negative FIPA families were studied and
124 affected subjects underwent sequencing of CDKN1B. Functional analysis of
putative CDKN1B mutations was performed using in silico and in vitro approaches.
Germline CDKN1B analysis revealed two nucleotide changes: c.286A>C (p.K96Q)
and c.356T>C (p.I119T). In vitro, the K96Q change decreased p27 affinity for Grb2
but did not segregate with pituitary adenoma in the FIPA kindred. The I119T
substitution occurred in a female patient with acromegaly. p27(I119T) shows an
abnormal migration pattern by SDS-PAGE. Three variants (p.S56T, p.T142T, and
c.605+36C>T) are likely nonpathogenic because In vitro effects were not seen. In
conclusion, two patients had germline sequence changes in CDKN1B, which led to
functional alterations in the encoded p27 proteins in vitro. Such rare CDKN1B
variants may contribute to the development of pituitary adenomas, but their low
incidence and lack of clear segregation with affected patients make CDKN1B
sequencing unlikely to be of use in routine genetic investigation of FIPA kindreds.
However, further characterization of the role of CDKN1B in pituitary tumorigenesis
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